News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...

The warning comes as demand for weight loss jabs continues to surge, particularly as the NHS began offering Wegovy in late 2023 and will start offering Mounjaro to patients in March 2025. They have ...

Millions of Brits are now eligible for the appetite-suppressing jabs which can come with unpleasant side effects - but NHS rationing means only a tiny fraction will be prescribed them ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

Novo sells semaglutide as Ozempic, Rybelsus and Wegovy. The CMS will treat the different forms as a single product in price ...

Eli Lilly & Co. ’s competing Mounjaro and Zepbound won’t be eligible for negotiation ... “Today’s announcement means ...